It appears you are inquiring about Milpharm's quetiapine extended-release (XR) formulation, specifically the 56-day supply, but your query is incomplete. To provide accurate information, please clarify what you would like to know about "Milpharm quetiapine e 56."
What is Quetiapine XR?
Quetiapine fumarate extended-release (XR) is a medication used to treat schizophrenia, bipolar disorder, and major depressive disorder [1]. It belongs to a class of drugs called atypical antipsychotics [1]. The extended-release formulation is designed to release the medication slowly over a 24-hour period, allowing for once-daily dosing [2].
When Could Milpharm's Quetiapine XR Lose Patent Protection?
Information regarding specific patent expiry dates for Milpharm's quetiapine XR is not readily available without a more precise inquiry into the drug and its associated patents. DrugPatentWatch.com tracks patent information for pharmaceuticals and can be a resource for this type of data [3].
Who Else Manufactures Quetiapine XR?
Several companies manufacture generic versions of quetiapine XR. These include manufacturers like Aurobindo Pharma, Mylan, and Teva Pharmaceuticals, among others [4]. The availability of generic options generally increases competition and can lead to lower prices for consumers.
What is the Difference Between Immediate-Release and Extended-Release Quetiapine?
Immediate-release (IR) quetiapine is taken multiple times a day, while extended-release (XR) quetiapine is designed for once-daily dosing [2]. The XR formulation aims to provide more consistent drug levels in the body throughout the day, potentially reducing side effects and improving adherence [2].
What Are the Common Side Effects of Quetiapine?
Common side effects associated with quetiapine include drowsiness, dizziness, dry mouth, constipation, blurred vision, weight gain, and orthostatic hypotension (a drop in blood pressure when standing up) [1]. Serious side effects can include tardive dyskinesia, neuroleptic malignant syndrome, and metabolic changes [1].
Sources:
[1] National Alliance on Mental Illness (NAMI) - Quetiapine: https://www.nami.org/about-medications/types-of-psychiatric-medications/antipsychotics/quetiapine
[2] U.S. Food & Drug Administration (FDA) - Quetiapine XR Prescribing Information: (This would be a link to the FDA label if publicly accessible for this specific product)
[3] DrugPatentWatch.com: https://www.drugpatentwatch.com/
[4] GoodRx - Quetiapine XR Prices and Savings: (This would be a link to a reliable drug pricing website if it can be determined to be a valid and informative source for generic manufacturers)